1-2 of 2
Martha Arellano
Close
Sort by
Journal Articles

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Clinical Trials & Observations
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, Sarah E. Church, Tressa Hood, Anbarasu Lourdusamy, Michael P. Rettig, Ibrahim Aldoss, Anjali S. Advani, John Godwin, Matthew J. Wieduwilt, Martha Arellano, John Muth, Tung On Yau, Farhad Ravandi, Kendra Sweet, Heidi Altmann, Gemma A. Foulds, Friedrich Stölzel, Jan Moritz Middeke, Marilena Ciciarello, Antonio Curti, Peter J. M. Valk, Bob Löwenberg, Ivana Gojo, Martin Bornhäuser, John F. DiPersio, Jan K. Davidson-Moncada, Sergio Rutella
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5011–5024.
https://doi.org/10.1182/bloodadvances.2020002512
Published: 2020
Includes: Supplemental data
Journal Articles

Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study

Clinical Trials & Observations
Guillermo Garcia-Manero, Yasmin Abaza, Koichi Takahashi, Bruno C. Medeiros, Martha Arellano, Samer K. Khaled, Mrinal Patnaik, Olatoyosi Odenike, Hamid Sayar, Mohan Tummala, Prapti Patel, Lori Maness-Harris, Robert Stuart, Elie Traer, Kasra Karamlou, Abdulraheem Yacoub, Richard Ghalie, Ruben Giorgino, Ehab Atallah
Journal: Blood Advances
Blood Adv (2019) 3 (4): 508–518.
https://doi.org/10.1182/bloodadvances.2018027409
Published: 2019
Includes: Supplemental data